Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.63 |
| ▸ | STAT1 | P42224 | 1/20 | 0.63 |
| ▸ | TOP1 | P11387 | 4/20 | 0.39 |
| ▸ | CYCS | P99999 | 3/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 4/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL585640 | 0.88 | STAT3 (0.68) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL584789 | 0.87 | STAT3 (0.67) | STAT3STAT1TOP1CYCSTERT | |
| Zinc Ion SCHEMBL31127546 | 0.87 | STAT3 (0.66) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL5671488 | 0.86 | STAT3 (0.52) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL3352961 | 0.86 | STAT3 (0.64) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL29403134 | 0.86 | STAT3 (0.64) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL3107248 | 0.85 | STAT3 (0.64) | STAT3STAT1TOP1CYCSTERT | |
| SCHEMBL29402399 | 0.85 | STAT3 (0.63) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL28459011 | 0.85 | STAT3 (0.63) | STAT3STAT1TOP1CYCSENPP2 | |
| SCHEMBL14973450 | 0.85 | STAT3 (0.63) | STAT3STAT1TOP1CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1305317-B1 | DIHYDROPORPHYRIN DERIVATIVES AND THEIR USES | ANULM ASS NATAISE POUR L UTILI (FR) | 2004-09-15 | — | — | EP | disclosed |
| US-20040022734-A1 | Dihydroporphyrin derivatives and their uses | ANNULM, ASSOCIATION NANTAISE POUR L'UTILISATION DE LA LUMIERE EN MEDECINE (FR) | 2004-02-05 | — | — | US | disclosed |
| EP-1305317-A1 | DIHYDROPORPHYRIN DERIVATIVES AND THEIR USES | Anulm Association Nataise pour l'Utilisation de la Lumière en Medicine (FR) | 2003-05-02 | — | — | EP | disclosed |
| WO-2002010173-A1 | DIHYDROPORPHYRIN DERIVATIVES AND THEIR USES | ANULM ASSOCIATION NATAISE POUR L'UTILISATION DE LA LUMIERE EN MEDECINE (FR) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040022734-A1 | Dihydroporphyrin derivatives and their uses | PPOX, PPIF, DHPS | STAT3 2489/4885STAT1 4379/4885TOP1 1341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.